Baird biotech analyst Jack Allen recaps ASH and other recent news, and shares his outlook for top names in 2025

Dimension's Zavain Dar talks about raising a $500M second fund, and describes the firm's ethos of investing in companies that are highly focused in both life sciences and technology

NewYorkBIO CEO Jennifer Hawks Bland discusses their annual event at the New York Stock Exchange and what is on the mind of companies today

ApexOnco's Jacob Plieth shares his take on what to watch for at the 2024 ASH Annual Meeting

London Healthcare Week: Forbion Managing Partner Sander Slootweg shares his thoughts on the year ahead, the IPO market, M&A environment, areas of interest, and more

From Seoul: Kicking off BiotechTV's one week visit to Korea by getting an overview of the growth and current state of biotech in the country from KoreaBIO

SITC 2024: Parker Institute for Cancer Immunotherapy CSO John Connolly gives an overview of the latest advances in IO

BioHouston CEO Ann Tanabe kicks off the 2024 Texas Life Science Forum

BIO-Europe: Pareto Securities' Biotech Analyst Dan Akschuti shares his thoughts on the conference and discusses recent company successes in the nordic region

BIO-Europe: Karolinska Institutet professor and physician Anna Wedell discusses the work she is doing and what areas of research excite her today

BIO-Europe: The CEO of Flerie, a publicly traded life sciences investment firm, discuses the firm's investment strategy and the health of biotech in the region

The CEO of the nonprofit MassChallenge describes the way it supports startups and entrepreneurs, and why it has chosen Dallas as its second region of major focus in the U.S. outside of Boston

Biotech entrepreneur RA Session II describes converting science from UT Southwestern into companies - he currently has a new one that is in stealth mode

The CEO of LH Capital, a key supporter of the life sciences industry in North Texas, describes the progress the biotech community here has made over the last year

UT Southwestern professor Philipp Scherer talks about his work focusing on adipose cells and a local biotech company, PriveBio, that has come out of it

Piper Sandler analyst Biren Amin discusses recent news in ATTR cardiomyopathy, ophthalmology, Duchenne muscular dystrophy, and more

Backed by a conglomerate that has pharma expertise, Rome based Angelini Ventures has a $300M fund that invests broadly in life sciences and healthcare

The Foundation for Innovation and Tech Transfer has consolidated business development and tech transfer for 7 institutions in northern Italy to expedite the commercialization of the area's research

The co-founder of the startup Ousia Pharma describes working from Copenhagen's BioInnovation Institute on his company's next-generation enhancer to GLPs

Biotech veteran Hans Schikan gives an overview of the Netherlands' life sciences scene